Cargando…

Schnyder corneal dystrophy-associated UBIAD1 mutations cause corneal cholesterol accumulation by stabilizing HMG-CoA reductase

Schnyder corneal dystrophy (SCD) is a rare genetic eye disease characterized by corneal opacification resulted from deposition of excess free cholesterol. UbiA prenyltransferase domain-containing protein-1 (UBIAD1) is an enzyme catalyzing biosynthesis of coenzyme Q10 and vitamin K(2). More than 20 U...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Shi-You, Tang, Jing-Jie, Xiao, Xu, Qi, Wei, Wu, Suqian, Jiang, Chao, Hong, Jiaxu, Xu, Jianjiang, Song, Bao-Liang, Luo, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668851/ https://www.ncbi.nlm.nih.gov/pubmed/31323021 http://dx.doi.org/10.1371/journal.pgen.1008289

Ejemplares similares

Schnyder corneal dystrophy-associated UBIAD1 inhibits ER-associated degradation of HMG CoA reductase in mice
por: Jo, Youngah, et al.
Publicado: (2019)

UBIAD1 Mutation Alters a Mitochondrial Prenyltransferase to Cause Schnyder Corneal Dystrophy
por: Nickerson, Michael L., et al.
Publicado: (2010)

A novel UBIAD1 mutation identified in a Chinese family with Schnyder crystalline corneal dystrophy
por: Jing, Yang, et al.
Publicado: (2009)

A mutation in the UBIAD1 gene in a Han Chinese family with Schnyder corneal dystrophy
por: Du, Chunyu, et al.
Publicado: (2011)

Identification of the First De Novo UBIAD1 Gene Mutation Associated with Schnyder Corneal Dystrophy
por: Lin, Benjamin R., et al.
Publicado: (2016)

Schnyder corneal dystrophy and associated phenotypes caused by novel and recurrent mutations in the UBIAD1 gene
por: Evans, Cerys J., et al.
Publicado: (2018)

Mutations in the UBIAD1 Gene, Encoding a Potential Prenyltransferase, Are Causal for Schnyder Crystalline Corneal Dystrophy
por: Orr, Andrew, et al.
Publicado: (2007)

Clinical diversity in patients with Schnyder corneal dystrophy—a novel and known UBIAD1 pathogenic variants
por: Sarosiak, Anna, et al.
Publicado: (2018)

Schnyder Corneal Dystrophy in a Saudi Arabian Family with Heterozygous UBIAD1 Mutation (p.L121F)
por: Al-Ghadeer, Huda, et al.
Publicado: (2011)

The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase
por: Schumacher, Marc M, et al.
Publicado: (2015)

Multimodal Imaging Features of Schnyder Corneal Dystrophy
por: Ghazal, Wassim, et al.
Publicado: (2020)

Deep phototherapeutic keratectomy for Schnyder corneal dystrophy
por: Chen, Ching-An, et al.
Publicado: (2022)

Stromal corneal dystrophy (possible Schnyder’s dystrophy) with peripheral corneal degeneration – diagnostic and therapeutic challenges
por: Zemba, Mihail, et al.
Publicado: (2018)

Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
por: Jiang, Shi-You, et al.
Publicado: (2018)

Analysis of conjunctival fibroblasts from a proband with Schnyder corneal dystrophy
por: Mehta, Jodhbir S., et al.
Publicado: (2008)

A Mouse Model of Schnyder Corneal Dystrophy with the N100S Point Mutation
por: Dong, Fei, et al.
Publicado: (2018)

Enhanced ER-associated degradation of HMG CoA reductase causes embryonic lethality associated with Ubiad1 deficiency
por: Jo, Youngah, et al.
Publicado: (2020)

Type 1 polyisoprenoid diphosphate phosphatase modulates geranylgeranyl-mediated control of HMG CoA reductase and UBIAD1
por: Elsabrouty, Rania, et al.
Publicado: (2021)

Predictive Modeling of HMG-CoA Reductase Inhibitory Activity and Design of New HMG-CoA Reductase Inhibitors
por: Samizo, Shigeyoshi, et al.
Publicado: (2023)

Acetaldehyde Dehydrogenase 2 regulates HMG-CoA reductase stability and cholesterol synthesis in the liver
por: Zhong, Shanshan, et al.
Publicado: (2021)

The Cholesterol-Lowering Effect of Alisol Acetates Based on HMG-CoA Reductase and Its Molecular Mechanism
por: Xu, Fei, et al.
Publicado: (2016)

Inhibition of HMG CoA reductase reveals an unexpected role for cholesterol during PGC migration in the mouse
por: Ding, Jiaxi, et al.
Publicado: (2008)

Pleiotropic effects of the HMG-CoA reductase inhibitors
por: Mihos, Christos G, et al.
Publicado: (2011)

Single dose testosterone increases total cholesterol levels and induces the expression of HMG CoA Reductase
por: Gårevik, Nina, et al.
Publicado: (2012)

Cholesterol, C-Reactive Protein, and Periodontitis: HMG-CoA-Reductase Inhibitors (Statins) as Effect Modifiers
por: Meisel, Peter, et al.
Publicado: (2011)

Potential natural inhibitors of xanthine oxidase and HMG-CoA reductase in cholesterol regulation: in silico analysis
por: Marahatha, Rishab, et al.
Publicado: (2021)

Novel Mutations Associated With Various Types of Corneal Dystrophies in a Han Chinese Population
por: Zhang, Jing, et al.
Publicado: (2019)

Comparison of human corneal cell density by age and corneal location: an in vivo confocal microscopy study
por: Zheng, Tianyu, et al.
Publicado: (2016)

The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation
por: Gelosa, Paolo, et al.
Publicado: (2007)

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo
por: Noël, Martin, et al.
Publicado: (2004)

Structural and functional characterization of HMG-COA reductase from Artemisia annua
por: Kiran, Usha, et al.
Publicado: (2010)

Transcription of the three HMG-CoA reductase genes of Mucor circinelloides
por: Nagy, Gábor, et al.
Publicado: (2014)

Functional Implications of HMG-CoA Reductase Inhibition on Glucose Metabolism
por: Han, Ki Hoon
Publicado: (2018)

Chronic Onset Form of Anti-HMG-CoA Reductase Myopathy
por: Lorenzo-Villalba, Noel, et al.
Publicado: (2021)

Eupatilin Alleviates Hyperlipidemia in Mice by Inhibiting HMG-CoA Reductase
por: Kim, Kyung-Joo, et al.
Publicado: (2023)

Are Point Mutations in HMG-CoA Reductases (Hmg1 and Hmg2) a Step towards Azole Resistance in Aspergillus fumigatus?
por: Gonzalez-Jimenez, Irene, et al.
Publicado: (2021)

The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases
por: Friesen, Jon A, et al.
Publicado: (2004)

Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
por: Würtz, Peter, et al.
Publicado: (2016)

Oxidative Stress and Cellular Protein Accumulation Are Present in Keratoconus, Macular Corneal Dystrophy, and Fuchs Endothelial Corneal Dystrophy
por: Vottonen, Linda, et al.
Publicado: (2023)

Inhibitory effects of tangeretin and trans-ethyl caffeate on the HMG-CoA reductase activity: Potential agents for reducing cholesterol levels
por: Pangestika, Inten, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t20pnm9qe5dbu55eu869j2d3vl